San Diego-based Elevation Pharmaceuticals
announced today that it has drawn down a $17M, tranched Series A financing for the company, and also appointed a number of executives. The company also said it has named Jaisim Shah as Senior Vice President and Chief Business officer, and named Pravin Soni as Senior Vice President and Chief Technical Officer. Shah was previously at Zelos Therapeutics, and has also served at Zelos Therapeutics, CytRx, Facet Biotech, PDL BioPharma, F. Hoffman-LaRoche, and Bristol-Myers Squibb. Soni hs served at Alexza Pharmaceuticals, Cygnus, and Raychem. Elevation Pharmaceuticals is venture backed by Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners.
posted on Monday, September 26, 2011 (Link to more information)
> Elevation Pharmaceuticals Acquired For $430M
> Elevation Pharmaceuticals Gains $30M
> Elevation Pharmaceuticals Raises $30M
> Homestore Gets $100M From Elevation Partners
> Spectrum Pharmaceuticals Names Chief Scientific Officer